REQUEST A DEMO
Total
USD $0.00
Search more companies

Inpharma Trading SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Inpharma Trading SIA Profile Updated: May 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Inpharma Trading SIA is an enterprise in Latvia, with the main office in Ropazu municipality. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on September 24, 2019. Inpharma Trading SIA currently employs 2 (2023) people. From the latest financial highlights, Inpharma Trading SIA reported a net sales revenue drop of 95.76% in 2025. Over the same period, its total assets decreased by 29.9%.

Headquarters
Garkalnes pag., Bukulti, Rasas iela 1A
Ropazu municipality; Ropazu municipality; Postal Code: 1024

Contact Details: Purchase the Inpharma Trading SIA report to view the information.

Basic Information
Total Employees:
Purchase the Inpharma Trading SIA report to view the information.
Registered Capital:
Purchase the Inpharma Trading SIA report to view the information.
Financial Auditors:
Purchase the Inpharma Trading SIA report to view the information.
Incorporation Date:
September 24, 2019
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Inpharma Trading SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-95.76%
Total Operating Revenue
-89.9%
Operating Profit
N/A
Net Profit/Loss for the Period
N/A
Total Assets
-29.9%
Total Equity
-21.77%
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-2.05%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?